X-ray diffraction III: Pharmaceutical applications

Spectroscopy (Santa Monica)

Volumn 16, Issue 7, 2001, Pages 14-18

  Brittain, Harry G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24044540785     PISSN: 08876703     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. J. Anwar, "Pharmaceuticals: Design and Development of Drug Delivery Systems," in Industrial Applications of X-ray Diffraction, F.H. Chung and D.K. Smith, Eds. (Marcel Dekker, New York, 2000), pp. 539-553.
2. H.G. Brittain, Spectroscopy 15(6), 44-49 (2000).
3. H.G. Brittain, Spectroscopy 15(7), 34-39 (2000).
4. M.M. Woolfson, X-ray Crystallography (Cambridge University Press, Cambridge, 1970).
5. G.H. Stout and L.H. Jensen, X-ray Structure Determination: A Practical Guide (Macmillan Co., New York, 1968).
6. M.O. Boles, R.J. Girven, and P.A.C. Gane, "The Structure of Amoxicillin Trihydrate and a Comparison with the Structures of Ampicillin," Acta Cryst. B34, 461 (1978).
7. W.H. Bragg and W.L. Bragg, X-rays and Crystal Structure (G. Bell & Sons, London, 1918).
8. "X-ray Diffraction," General Chapter (941), USP 23/NF 18 (The United States Pharmacopoeial Convention, Rockville, MD, 1995), pp. 1843-1844.
9. G. Indrayanto et al., "Benzoic Acid," in Analytical Profiles of Drug Substances and Excipients, Volume 26, H.G. Brittain, Ed. (Academic Press, San Diego, CA, 1999), pp. 10-11.
10. "X-ray Diffraction," General Chapter (941), USP 24/ NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), pp. 2005-2007.
11. M. Otsuka, F. Kato, and Y. Matsuda, "Comparative Evaluation of the Degree of Indomethacin Crystallinity by Chemoinfometrical Fourier-Transformed Near-Infrared Spectroscopy and Conventional Powder X-ray Diffractometry," AAPS-PharmSci. 2, Issue 1, Paper 9 (2000).
12. S. Byrn et al., "Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations," Pharm. Res. 12, 945-954 (1995).
13. H.G. Brittain, "Foundations of Chemical Microscopy I: Solid-State Characterization of 5-Nitrobarbituric Acid (Dilituric Acid) and its Complexes with Group IA and Group IIA Cations," J. Pharm. Biomed. Anal. 15, 1143-1155 (1997).
14. H.G. Brittain, unpublished results.
15. S. Agatonovic-Kustrin et al., "Powder Diffractometric Assay of Two Polymorphic Forms of Ranitidine Hydrochloride," Int. J. Pharm. 184, 107-114 (1999).
16. Z.G. Li et al., "Polymorph Determination for the GP IIb/IIIa Antagonist, Roxifiban, Using a Combination of Electron Diffraction and Synchrotron X-ray Powder Diffraction Techniques," J. Pharm. Sci. 88, 297-301 (1999).
17. G. A. Stephenson et al., "Formation of Isomorphic Desolvates: Creating a Molecular Vacuum," J. Pharm. Sci. 87, 536-542 (1999).
18. E. Yonemochi et al., "Physicochemical Properties of Amorphous Clarithromycin Obtained by Grinding and Spray Drying," Eur. J. Pharm. Sci. 7, 331-338 (1999).